PBA
VRNA

Paradigm Biocapital Advisors’s Verona Pharma VRNA Stock Holding History

Paradigm Biocapital Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-721,087
2024
Q2 		$10.4M Buy
+721,087
2023
Q4 		– Sell
-926,432
2023
Q3 		$15.1M Buy
926,432
+32,571
2023
Q2 		$18.9M Sell
893,861
-68,500
2023
Q1 		$19.3M Buy
+962,361